Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Oldweedon Aug 13, 2019 8:47pm
143 Views
Post# 30025198

RE:RE:RE:RE:RE:This CPG multinational is sure doing well!

RE:RE:RE:RE:RE:This CPG multinational is sure doing well!
kingbear wrote: Hemp derived CBD is allowed in the U.S, but not CBD from the actual bud of the plant, there is a big difference. 
Oldweed wrote:
kingbear wrote: They can't get involved with CRESCO as it is federally illegal for them to do so. Any big player that wants in has to invest in a CDN LP. Aphria should be able to land a partner.
Oldweed wrote: Possibly, it is a good fit and there are other CPG focus companies out their also looking for a partner and thier are other MJ players out their with a core focus in CPG......such as CRESCO...I think you will see established CPG brands move in to CBD first to get their feet wet in CBD first and then move into THC when the US legalizes rec. I only say this because Canada is a smaller market and is very brand restrictive, these big US companies won't dive in where their brand is shackled, at least not for now only tobacco and alcohol have been willing to take the plunge. One thing is for sure i tis gonna be an interesting year:) Sharks are circling!
I think the door to CBD products is now open in the US, only the THC remains to be legalized, this is why I think branded CPG companies will move in CBD first because their brands can't be advertised in Canada. CBD is now an acceptable CPG product as long as your not selling it as medicine with no FDA approval!
 

 



Yep, and this in my opinion is why there is a stamped to hemp crops....from there CPG will normalize the market and build on the established brand lineup with CBD and flood the market with rec THC when the feds give their blessing. CRESCO is not restricted by the NYSE like CGC or CRON so yes they can be acquired and continue to build an alternative national US brand for THC rec in the interim. This is pure speculation but the landscape the way it is and Canada (HC) and TRST debacle in play this is a brand risk, the US is highly regulated and splintered and complex, no current CPG can go it alone and no CPG will continue to watch these upstarts eat into their bottom line. I'm thinking CRESCO will be the first CPG brand and CURA or CWEB the likely first pharma buyout but who knows really!

Bullboard Posts